Skip to content

EDTA Solution R30164501

by Remel Europe Limited

EDTA Solution R30164501 is a medical device (FDA Class II; FDA product code GTJ, Antisera, All Groups, N. Meningitidis) made by Remel Europe Limited, listed in FDA GUDID since 21 Jul 2021 (UDI-DI 05056080501567), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number05056080501567 UDI-DI Date21 Jul 2021ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
EDTA Solution
Generic name
Multiple meningitis-associated bacteria antigen IVD, reagent
Model / reference
R30164501
Primary DI / UDI-DI
05056080501567
FDA product code
GTJ
GMDN term
Multiple meningitis-associated bacteria antigen IVD, reagent
Device class
Class II
Regulation number
866.3390
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GTJ (Antisera, All Groups, N. Meningitidis).

Other devices from Remel Europe Limited

See all devices from Remel Europe Limited →

Properties

  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (12, all answered No)